Skip to main content
Anatolian Journal of Cardiology logoLink to Anatolian Journal of Cardiology
. 2014 Apr 16;15(4):313–317. doi: 10.5152/akd.2014.5373

Acute effects of ultrafiltration on aortic mechanical properties determined by measurement of pulse wave velocity and pulse propagation time in hemodialysis patients

Banu Şahin Yıldız 1,, Alparslan Şahin 1, Nazire Başkurt Aladağ 1, Gülgün Arslan 1, Hakan Kaptanoğulları 2, İbrahim Akın 3, Mustafa Yıldız 4
PMCID: PMC5336841  PMID: 25413228

Abstract

Objective:

The effects of acute hemodialysis session on pulse wave velocity are conflicting. The aim of the current study was to assess the acute effects of ultrafiltration on the aortic mechanical properties using carotid-femoral (aortic) pulse wave velocity and pulse propagation time.

Methods:

A total of 26 (12 women, 14 men) consecutive patients on maintenance hemodialysis (mean dialysis duration: 40.7±25.6 (4-70) months) and 29 healthy subjects (13 women, 16 men) were included in this study. Baseline blood pressure, carotid-femoral (aortic) pulse wave velocity, and pulse propagation time were measured using a Complior Colson device (Createch Industrie, France) before and immediately after the end of the dialysis session.

Results:

While systolic blood pressure, diastolic blood pressure, mean blood pressure, pulse pressure, and pulse wave velocity were significantly higher in patients on hemodialysis than in healthy subjects, pulse propagation time was significantly higher in healthy subjects. Although body weight, systolic blood pressure, diastolic blood pressure, mean blood pressure, pulse pressure, and pulse wave velocity were significantly decreased, heart rate and pulse propagation time were significantly increased after ultrafiltration. There was a significant positive correlation between pulse wave velocity and age, body height, waist circumference, systolic blood pressure, diastolic blood pressure, mean blood pressure, pulse pressure, and heart rate.

Conclusion:

Although hemodialysis treatment may chronically worsen aortic mechanical properties, ultrafiltration during hemodialysis may significantly improve aortic pulse wave velocity, which is inversely related to aortic distensibility and pulse propagation time.

Keywords: ultrafiltration, hemodialysis, aortic mechanical properties, pulse wave velocity, pulse propagation time

Introduction

Cardiovascular complications, such as accelerated atherosclerosis and heart failure, are important causes of death in patients with hemodialysis, which is the generally used renal replacement therapy (1). Dialysis works on the principles of the diffusion of solutes, including urea, potassium, and phosphorus, and ultrafiltration of fluid across a semi-permeable membrane. In addition to end-stage renal disease, ultrafiltration has recently become an alternative strategy to diuretic therapy for the treatment of patients with decompensated heart failure (2). Alterations of large arterial mechanical properties, such as decreased aortic compliance and/or distensibility, assessed by arterial pulse wave velocity, are common in hemodialysis patients and appear to contribute to increased cardiovascular morbidity and mortality (3-6). Reduced arterial elasticity may impair large artery cushioning function and results in increased left ventricular afterload and reduced coronary artery perfusion (7). However, it is not clear whether ultrafiltration acutely affects large arterial mechanical properties. Therefore, the aim of the current study was to assess the acute effects of ultrafiltration on aortic mechanical properties. We measured carotid-femoral (aortic) pulse wave velocity and pulse propagation time, which is inversely related to pulse wave velocity, as parameters of aortic mechanical properties, in patients on hemodialysis just before and after hemodialysis with an ultrafiltration session.

Methods

Patient population and study protocol

A total of 26 consecutive patients on maintenance hemodialysis (mean dialysis duration: 40.7±25.6 (4-70) months) and 29 healthy subjects were included in this study. Patients who were treated with conventional hemodialysis received 4 hours of treatment thrice weekly with a target blood pump speed of 300 mL/min and dialysate flow rate of 500 mL/min. It was used the arteriovenous fistula during the dialysis period. Dry weight was considered optimal when patients remained without symptoms of dyspnea, orthopnea, or edema during the inter- dialytic period. All dialysis treatments used Fresenius 4008 machines (Fresenius Medical Care, Germany), polysulphone membranes, and bicarbonate-buffered dialysate [Fresenius Medical Care SK-F 213 (PGS 22)]. A standard calcium bath was used and adjusted as clinically indicated. Patients’ diets were liberalized, and phosphate binders were used. Also, intravenous erythropoietin and iron supplementation and antihypertensive agents, including angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, beta-blockers or calcium channel blockers, were adjusted as clinically indicated. Eleven patients (6 men, 5 women) were hypertensive and were taking angiotensin receptor blockers, angiotensin- converting enzyme inhibitors, beta-blockers, or calcium channel blockers.

The study exclusion criteria thus included previous myocardial infarction, peripheral arterial disease, cerebrovascular disease, valvular heart disease, history of dialysis-induced hypotension, atrial fibrillation, and 2nd-3rd degree atrioventricular block. Because of technical limitations (8), we did not measure arterial pulse wave velocity at a body height <120 cm, body weight <30 kg, and body mass index >35 kg/m2. None of the patients had a smoking or alcohol intake history. All subjects gave their consent for inclusion in the study, and the local ethical committee approved it. The investigation conforms to the principles outlined in the Declaration of Helsinki.

Each patient was placed in a supine position and studied first at 8:00 AM, before the dialysis session. Pulse wave velocity was measured before and after the dialysis session on the first dialysis day. Following measurement of baseline blood pressure, we evaluated carotid-femoral (aortic) pulse wave velocity and pulse propagation time using a Complior Colson device (Createch Industrie, France) (8). The same protocol was repeated immediately after the end of the dialysis session.

Body weight, body height, and waist-hip ratio measurements

Body weight (kg) and body height (m) were calculated using bascule and metric measures, respectively. The circumference of waist and the circumference of the hip were calculated by a tape line.

Measurement of body temperature

Body temperature was measured with an axillary mercury thermometer.

Blood pressure measurement

The arterial blood pressure of the subjects was measured by the same clinician. The subjects were in supine position and had rested at least 20 minutes before the measurement. The blood pressure was measured using a mercury sphygmomanometer with a cuff appropriate to the arm circumference (Korotkoff phase I for systolic blood pressure and V for diastolic blood pressure). Blood pressure measurements were performed twice for each subject, and their mean was used for the statistical analysis.

Pulse pressure = systolic blood pressure - diastolic blood pressure

Mean blood pressure = (systolic blood pressure + 2 X diastolic blood pressure)/3

Aortic pulse wave velocity and pulse propagation time measurement

Arterial pulse wave velocity and pulse propagation time were measured using the automatic Complior Colson (France) device; the technical characteristics of this device have been described, and the estimated inter- and intraobserver repeatability coefficient values are reported to be >0.9 (8). Pulse wave velocity is calculated from measurements of pulse transit time and the distance traveled by the pulse between two recording sites (the right femoral and common carotid arteries): pulse wave velocity=distance (meters)/transit time (seconds). Different techniques can be used for the measurement of pulse wave velocity, such as Doppler and pressure (8). In this study, we used the TY-306 pressure transducer (Fukuda Co); this transducer has a large frequency bandwidth, from less than 0.1 Hz to more than 100 Hz, which largely covers the principal frequency harmonics of the pressure wave at different heart rates and thus allows its application for pulse wave velocity measurement. For automatic measurement of pulse wave velocity, pressure waveforms are digitized at different rates according to the distance between the recording sites; the sampling acquisition frequency is 500 Hz for carotid-femoral pulse wave velocity. The two pressure waveforms are stored in a recirculating memory buffer, half of which is displayed at any given time. During preprocessing analysis, the gain of each waveform was adjusted to obtain an equal signal for the two waveforms. During pulse wave velocity measurements, after pulse waveforms of sufficient quality were recorded, the digitization process was initiated by the operator, and automatic calculation of the time delay between two upstrokes was started. The measurement was repeated over 10 different cardiac cycles, and the mean value was used for the final analysis.

Statistical analysis

Statistics were obtained using the ready-to-use software SPSS (version 8.0, SPSS Inc, Chicago, IL, USA). All of the values are expressed as means±SD. The Kolmogorov-Smirnov test was used to test the normality of distribution of continuous variables. Student t-test was used to examine the differences between hemodialysis patients and healthy subjects. The t-test for paired data was used to examine the differences between the pre- and post-dialysis periods. Relations between pulse wave velocity and other variables, including anthropometric and hemodynamic parameters, were calculated using Pearson's correlation tests and multivariate tests. A p <0.05 was considered significant.

Results

The study was composed of 26 hemodialysis patients (female: 12, male: 14, mean age: 39.8±15.4) and 29 healthy individuals (female: 13, male: 16; mean age: 36.5±9.7). There was no significant difference between the groups in terms of age, weight, height, waist circumference, hip circumference, heart rate, and pulse wave velocity (Table 1). While systolic blood pressure, diastolic blood pressure, mean blood pressure, pulse pressure, and pulse wave velocity (Fig. 1) were significantly higher in patients with hemodialysis than in healthy subjects, pulse propagation time was significantly higher in healthy subjects (Table 1). Although body weight (mean body weight loss 1.88±1.27 kg), systolic blood pressure, diastolic blood pressure, mean blood pressure, pulse pressure, and pulse wave velocity were significantly decreased, heart rate and pulse propagation time were significantly increased after ultrafiltration (Table 2). Although we found a significant positive correlation between pulse wave velocity and age, body height, waist circumference, systolic blood pressure, diastolic blood pressure, mean blood pressure, pulse pressure, and heart rate, we found a significant negative correlation between pulse wave velocity and pulse propagation time (Table 3). In the multivariate analysis, waist circumference was an independent predictor of pulse wave velocity (model; F=2.180, p=0.011; for waist circumference F=4.645, p=0.046). Five patients (2 men, 3 women) had a history of type II diabetes mellitus. Four diabetic patients were also hypertensive. All antihypertensive drugs were withheld for a minimum of 12 hours before the study.

Table 1.

Antropometric and hemodynamic values in hemodialysis patient and healthy subjects

Hemodialysis patient Healthy subjects P
Age, years 39.8±15.4 36.5±9.7 0.36
Weight, kg 65.03±10.77 70.13±11.78 0.10
Height, m 165.73±9.78 165.51±7.03 0.92
Waist circumference, cm 84.26±7.97 87.82±10.23 0.15
Hip circumference, cm 95.15±5.51 97.24±5.51 0.16
Systolic blood pressure, mm Hg 141.34±20.66 113.62±12.09 <0.001
Diastolic blood pressure, mm Hg 82.50±14.64 72.75±7.62 0.004
Mean blood pressure, mm Hg 101.84±16.33 86.03±7.33 <0.001
Pulse pressure, mm Hg 58.84±9.62 40.17±10.64 <0.001
Heart rate, beat/min 81.50±8.91 76.34±10.15 0.05
Pulse wave velocity, m/s 10.99±3.08 9.27±1.45 0.01
Pulse propagation time, s 57.22±12.67 66.96±8.93 0.002

Figure 1.

Figure 1

The results of pulse wave velocity differences between hemodialysis patients and healthy subjects

HP - hemodialysis patients; HS - healthy subjects; PWV - pulse wave velocity (m/s)

Table 2.

Changing parameters in pre- and post-dialysis period

Pre-dialysis period Post-dialysis period P
Weight, kg 65.03±10.77 63.15±10.93 <0.001
Systolic blood pressure, mm Hg 141.34±20.66 122.50±14.64 <0.001
Diastolic blood pressure, mm Hg 82.50±14.64 75.76±9.66 0.001
Mean blood pressure, mm Hg 101.84±16.33 90.88±10.72 <0.001
Pulse pressure, mm Hg 58.84±9.62 47.11±8.26 <0.001
Heart rate, beat/min 81.50±8.91 89.53±10.16 <0.001
Pulse wave velocity, m/s 11.21±3.11 10.48±2.58 0.02
Pulse propagation time, s 55.61±11.80 58.97±12.36 0.04

Table 3.

Correlation between pulse wave velocity and anthropometric and hemodynamic parameters

Pulse wave velocity (m/s) P r
Age, years <0.001 0.48
Dialysis duration, month 0.57 0.21
Weight, kg 0.16 0.18
Height, m 0.02 0.29
Waist circumference, cm 0.02 0.30
Hip circumference, cm 0.28 0.14
Systolic blood pressure, mm Hg 0.001 0.43
Diastolic blood pressure, mm Hg 0.008 0.35
Mean blood pressure, mm Hg 0.002 0.41
Pulse pressure, mm Hg 0.009 0.35
Heart rate, beat/min 0.01 0.33
Pulse propagation time, s <0.001 -0.87

Discussion

In this study, we found that body weight, systolic blood pressure, diastolic blood pressure, mean blood pressure, pulse pressure, and pulse wave velocity were significantly decreased and that heart rate and pulse propagation time were significantly increased after ultrafiltration in hemodialysis patients. Blood pressure, including systolic, diastolic, mean and pulse pressure, and pulse wave velocity were significantly higher in hemodialysis patients. Also, we found a significant positive correlation between pulse wave velocity and age, body height, waist circumference, systolic blood pressure, diastolic blood pressure, mean blood pressure, pulse pressure, and heart rate.

Arterial pulse wave velocity and pulse propagation time play an important clinical role in defining patients under high cardiovascular risk, such as coronary artery disease and chronic dialysis patients (9-12). Arterial pulse wave velocity is inversely correlated with pulse propagation time, depending on age, heart rate, and variation in blood pressure level, such as systolic blood pressure and pulse pressure (8, 13), as shown in our study. Pulse wave velocity becomes higher at advanced age and high blood pressure and lower at low blood pressure through mechanical changes in arterial wall stretching, resulting in a change in the contribution of elastin and collagen fibers to the elastic modulus (14). The effect of heart rate on pulse wave velocity was shown in human and animal studies (15, 16). Heart rate changes with atrial pacing are able to influence arterial distensibility (15, 16). Because the viscous component of the elastic wall is highly frequency-dependent, it can be expected that higher heart rates are associated with reduced arterial elasticity (17). Increased waist circumference and body mass index, which are traditional cardiovascular risk factors, might adversely affect cardiovascular conditions through hyperlipidemia, insulin resistance, and inflammation, and they might also exert adverse effects on the arterial system by increasing pulse wave velocity (18).

Pulse propagation time refers to the time it takes for a pulse wave to travel between two arterial sites, such as the carotid artery and femoral artery (19). The velocity at which this arterial pressure wave travels is directly proportional to blood pressure. An acute rise in blood pressure causes vascular tone to increase, and hence, the arterial wall becomes stiffer, causing the pulse propagation time to shorten. Conversely, when blood pressure falls, vascular tone decreases and pulse propagation time increases (19). Generally, there are two systems used for measuring the pulse propagation time (20). One of these techniques includes an arterial tonometer that records pressure waveforms. Pulse propagation time is measured from the foot of the carotid waveform to that of the femoral waveform using sequential recordings referenced to electrocardiography. The other technique, which was used in the current study, is the Complior system, in which carotid artery and femoral artery waveforms are recorded simultaneously using mechanotrans- ducers, and the timing is referenced to the point of maximum systolic upstroke.

Pulse wave velocity and/or arterial stiffness is well known as a predictive risk factor for cardiovascular events in patients on hemodialysis (3-6, 12, 21). However, the effect of acute hemodialysis on pulse wave velocity is conflicting. Some authors found no effect of hemodialysis on pulse wave velocity (22, 23), while other authors described a significant increase of pulse wave velocity or decreased arterial distensibility (20). An increase in heart rate after dialysis may be caused by activation of the sympathetic nervous system (24, 25). Sympathetic system activity exerts a tonic restraint on large artery distensibility, and sympathetic activation is accompanied by a reduction of arterial elasticity (26). Activation of the renin system by ultrafiltration may also lead to acute impairment of large artery distensibility (25). Kosch et al. (25) demonstrated that volume correction during the dialysis period may improve vascular function. Therefore, it is conceivable that a favorable effect on the vascular function tests of volume correction is offset by the simultaneous stimulation of the renin system and/or the sympathetic nervous system, resulting in the absence of an overall effect. Soubassi et al. (27) showed that aortic distensibility, evaluated by M-mode echocardiography, in the parasternal long-axis view in patients with end-stage renal disease is significantly lower than in normal subjects, and it is significantly improved after hemodialysis. Hydration status and its frequent changes appear to be the major determinants of both pulse wave velocity and changes in pulse wave velocity in hemodialysis patients, and these changes are independent of blood pressure (28, 29). Also, thermal changes during dialysis strongly influence intradialytic hemodynamics (30). Small increases in body temperature might affect the blood pressure response during dialysis. Furthermore, keeping the body temperature stable ameliorates left ventricular dysfunction. In order to eliminate the effects of temperature, we performed isothermic dialysis in this study. Another essential point that should be considered is that measures of arterial stiffness, such as pulse wave velocity, are also influenced by changes in serum ionized calcium levels in dialysis patients (21). LeBeouf et al. (31) found an association between relative changes in ionized calcium and an increase in postdialytic aortic pulse wave velocity, independent of blood pressure changes, using dialysate calcium concentrations closer to physiological concentrations. So, this should be kept in mind when interpreting our findings.

Study limitations

Several limitations are present in our study. The sample size of subjects was relatively small. Furthermore, the changes of cardiovascular diseases markers were obtained before and after only one hemodialysis session. Several measurements could be more persuasive and definitive. Because of technical limitations (8), we did not measure arterial pulse wave velocity at a body height <120 cm, body weight <30 kg, and body mass index >35 kg/m2. Therefore, the results of this study will need confirmation in larger studies.

Conclusion

Although chronic hemodialysis treatment may have worse aortic mechanical properties, ultrafiltration during hemodialysis may significantly improve aortic pulse wave velocity, which is inversely related to aortic distensibility and pulse propagation time.

Footnotes

Conflict of interest: None declared.

Peer-review: Externally peer-reviewed.

Authorship contributions: Concept - B.Ş.Y., A.Ş.; Design - B.Ş.Y., A.Ş.; Supervision - M.Y., B.Ş.Y.; Resource - N.B.A., H.K.; Materials - G.A., I.A.; Data collection &/or processing - H.K., G.A.; Analysis &/or interpretation - B.Ş.Y., N.B.A.; Literature search - A.Ş., H.K.; Writing - I.A., M.Y.; Critical review - I.A., M.Y.

References

  • 1.Ok E, Aşçı G, Toz H, Ok ES, Kircelli F, Yılmaz M, et al. Turkish Online Haemodiafiltration Study. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrol Dial Transplant. 2013;28:192–202. doi: 10.1093/ndt/gfs407. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 2.Hanna MA, Tang WH, Teo BW, O’Neill JO, Weinstein DM, Lau SM, et al. Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. Congest Heart Fail. 2012;18:54–63. doi: 10.1111/j.1751-7133.2011.00231.x. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 3.Sato M, Ogawa T, Otsuka K, Ando Y, Nitta K. Stiffness parameter ßas a predictor of the 4-year all-cause mortality of chronic hemodialysis patients. Clin Exp Nephrol. 2013;17:268–74. doi: 10.1007/s10157-012-0674-7. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 4.Groothoff JW, Lilien MR, van de Kar NC, Wolff ED, Davin JC. Cardiovascular disease as a late complication of end-stage renal disease in children. Pediatr Nephrol. 2005;20:374–9. doi: 10.1007/s00467-004-1624-8. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 5.Shroff R, Dégi A, Kerti A, Kis E, Cseprekál O, Tory K, et al. Cardiovascular risk assessment in children with chronic kidney disease. Pediatr Nephrol. 2013;28:875–84. doi: 10.1007/s00467-012-2325-3. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 6.Chen SC, Chang JM, Tsai YC, Su HM, Chen HC. Brachial-ankle pulse wave velocity and brachial pre-ejection period to ejection time ratio with renal outcomes in chronic kidney disease. Hypertens Res. 2012;35:1159–63. doi: 10.1038/hr.2012.114. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 7.Yıldız M, Altun A, Özbay G. Assessment of arterial distensibility in patients with cardiac syndrome X. Angiology. 2007;58:458–62. doi: 10.1177/0003319707305064. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 8.Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension. 1995;26:485–90. doi: 10.1161/01.hyp.26.3.485. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 9.Cecelja M, Chowienczyk P. Role of arterial stiffness in cardiovascular disease. JRSM Cardiovasc Dis. 2012;1:4–11. doi: 10.1258/cvd.2012.012016. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Charitaki E, Davenport A. Do higher dialysate calcium concentrations increase vascular stiffness in haemodialysis patients as measured by aortic pulse wave velocity? BMC Nephrol. 2013;14:189. doi: 10.1186/1471-2369-14-189. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Utescu MS, Couture V, Mac-Way F, De Serres SA, Marquis K, Larivière R, et al. Determinants of progression of aortic stiffness in hemodialysis patients: a prospective longitudinal study. Hypertension. 2013l;62:154–60. doi: 10.1161/HYPERTENSIONAHA.113.01200. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 12.Akdam H, Öğünç H, Alp A, Özbek Ö, Ömürlü İK, Yeniçerioğlu Y, et al. Assessment of volume status and arterial stiffness in chronic kidney disease. Ren Fail. 2014;36:28–34. doi: 10.3109/0886022X.2013.830224. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 13.Imura T, Yamamoto K, Kanamori K, Mikami T, Yasuda H. Non invasive ultrasonic measurement of the elastic properties of the human abdominal aorta. Cardiovasc Res. 1986;20:208–14. doi: 10.1093/cvr/20.3.208. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 14.Armentano RL, Barra JG, Levenson J, Simon A, Pichel RH. Arterial wall mechanics in conscious dogs. Assessment of viscous, inter- tial, and elastic moduli to characterize aortic wall behavior. Circ Res. 1995;76:468–78. doi: 10.1161/01.res.76.3.468. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 15.Albaladejo P, Copie X, Boutouyrie P, Laloux B, Déclère AD, Smulyan H, et al. Heart rate, arterial stiffness, and wave reflections in paced patients. Hypertension. 2001;38:949–52. doi: 10.1161/hy1001.096210. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 16.Mangoni AA, Mircoli L, Giannattasio C, Ferrari AU, Mancia G. Heart rate-dependence of arterial distensibility in vivo. J Hypertens. 1996;14:897–901. doi: 10.1097/00004872-199607000-00013. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 17.Hayward CS, Avolio AP, O’Rourke MF. Arterial pulse wave velocity and heart rate. Hypertension. 2002;40:e8–9. doi: 10.1161/01.hyp.0000038734.25997.a9. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 18.Wlazlo N, van Greevenbroek MM, Ferreira I, Jansen EJ, Feskens EJ, van der Kallen CJ, et al. Low-grade inflammation and insulin resistance independently explain substantial parts of the association between body fat and serum C3: the CODAM study. Metabolism. 2012;61:1787–96. doi: 10.1016/j.metabol.2012.05.015. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 19.Smith RP, Argod J, Pépin JL, Lévy PA. Pulse transit time: an appraisal of potential clinical applications. Thorax. 1999;54:452–7. doi: 10.1136/thx.54.5.452. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Millasseau SC, Stewart AD, Patel SJ, Redwood SR, Chowienczyk PJ. Evaluation of carotid-femoral pulse wave velocity: influence of timing algorithm and heart rate. Hypertension. 2005;45:222–6. doi: 10.1161/01.HYP.0000154229.97341.d2. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 21.Moor MB, Kruse A, Uehlinger DE, Eisenberger U. Arterial stiffness depends on serum ionized calcium levels during dialysis with regional citrate anticoagulation. Artif Organs. 2013;37:467–74. doi: 10.1111/aor.12037. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 22.Reising A, Sambale S, Donnerstag F, Schmidt JJ, Hafer C, Schmidt BM, et al. Effect of isovolemic, isothermic hemodialysis on cerebral perfusion and vascular stiffness using contrast computed tomography and pulse wave velocity. PLoS One. 2013;8:e56396. doi: 10.1371/journal.pone.0056396. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Georgianos PI, Sarafidis PA, Malindretos P, Nikolaidis P, Lasaridis AN. Hemodialysis reduces augmentation index but not aortic or brachial pulse wave velocity in dialysis-requiring patients. Am J Nephrol. 2011;34:407–14. doi: 10.1159/000331700. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 24.Su HM, Chang JM, Lin FH, Chen SC, Voon WC, Cheng KH, et al. Influence of different measurement time points on brachial-ankle pulse wave velocity and ankle-brachial index in hemodialysis patients. Hypertens Res. 2007;30:965–70. doi: 10.1291/hypres.30.965. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 25.Kosch M, Levers A, Barenbrock M, Matzkies F, Schaefer RM, Kisters K, et al. Acute effects of haemodialysis on endothelial function and large artery elasticity. Nephrol Dial Transplant. 2001;16:1663–8. doi: 10.1093/ndt/16.8.1663. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 26.Mangoni AA, Mircoli L, Giannattasio C, Mancia G, Ferrari AU. Effect of sympathectomy on mechanical properties of common carotid and femoral arteries. Hypertension. 1997;30:1085–8. doi: 10.1161/01.hyp.30.5.1085. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 27.Soubassi LP, Tousoulis D, Antoniades C, Lambrou S, Aggeli C, Chaniotis D, et al. Acute improvement of aortic mechanics following hemodialysis in patients with chronic renal failure. Clin Cardiol. 2006;29:506–10. doi: 10.1002/clc.4960291108. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Agarwal R, Light RP. Arterial stiffness and interdialytic weight gain influence ambulatory blood pressure patterns in hemodialysis patients. Am J Physiol Renal Physiol. 2008;294:F303–8. doi: 10.1152/ajprenal.00575.2007. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 29.Di Iorio B, Nazzaro P, Cucciniello E, Bellizzi V. Influence of haemodialysis on variability of pulse wave velocity in chronic haemodialysis patients. Nephrol Dial Transplant. 2010;25:1579–83. doi: 10.1093/ndt/gfp662. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 30.Usvyat LA, Kotanko P, van der Sande FM, Kooman JP, Carter M, Leunissen KM, et al. Circadian variations in body temperature during dialysis. Nephrol Dial Transplant. 2012;27:1139–44. doi: 10.1093/ndt/gfr395. [CrossRef] [DOI] [PubMed] [Google Scholar]
  • 31.LeBeouf A, Mac-Way F, Utescu MS, Chbinou N, Douville P, Desmeules S, et al. Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform. Nephrol Dial Transplant. 2009;24:3788–94. doi: 10.1093/ndt/gfp351. [CrossRef] [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Anatolian Journal of Cardiology are provided here courtesy of Turkish Society of Cardiology

RESOURCES